**Question:** The most malignant brain tumour is

A. Astrocytoma
B. Glioblastoma
C. Medulloblastoma
D. Ependymoma

**Correct Answer:** D. Ependymoma

**Core Concept:** Malignant brain tumors are classified based on their aggressiveness, potential for invasion, and ability to spread to other parts of the body. The term "malignant" indicates a high degree of cellular division and uncontrolled growth.

**Why the Correct Answer is Right:** Glioblastoma (GBM) is considered the most malignant brain tumor among the given options due to its aggressive behavior, rapid growth, and high tendency to recur. It arises from glial cells (astrocytes) and possesses distinct histopathological features that include hypercellularity, mitotic figures, and frequent necrosis.

**Why Each Wrong Option is Incorrect:**

A. Astrocytomas (including anaplastic astrocytomas and glioblastomas) are less malignant than glioblastomas multiforme (GBM). They are less aggressive and have a better prognosis compared to GBM.

B. Glioblastoma multiforme (GBM) is more malignant than glioblastoma anaplastic (non-GBM) due to its higher grade, rapid growth, and increased invasiveness.

C. Medulloblastomas are a type of malignant brain tumor that primarily affects children. While they are malignant, they are less aggressive than glioblastomas.

D. Ependymomas are less malignant than glioblastomas. They typically arise from ependymal cells lining the ventricles or the central canal of the spinal cord and are generally considered grade II or III tumors according to the World Health Organization (WHO) classification.

**Clinical Pearl:** Understanding the malignant potential of brain tumors is crucial for appropriate treatment planning and patient prognosis. Treatment strategies for malignant brain tumors often involve a combination of surgery, radiation therapy, and chemotherapy.

**Core Concept:** Brain tumors are classified into various grades based on their histopathological features and rate of proliferation. The World Health Organization (WHO) grading system is commonly used to classify brain tumors based on their cellular atypia, mitotic activity, and tumor necrosis. This grading helps healthcare professionals to determine the prognosis, treatment options, and expected response to therapy.